CVS Health Co. (NYSE:CVS) Shares Acquired by MGO One Seven LLC

MGO One Seven LLC raised its position in CVS Health Co. (NYSE:CVS) by 4.2% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 21,484 shares of the pharmacy operator’s stock after acquiring an additional 868 shares during the quarter. MGO One Seven LLC’s holdings in CVS Health were worth $964,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Principal Financial Group Inc. grew its stake in shares of CVS Health by 4.8% during the third quarter. Principal Financial Group Inc. now owns 1,434,476 shares of the pharmacy operator’s stock worth $90,200,000 after purchasing an additional 66,244 shares in the last quarter. Hall Laurie J Trustee boosted its position in shares of CVS Health by 25,484.4% during the 4th quarter. Hall Laurie J Trustee now owns 11,513 shares of the pharmacy operator’s stock worth $517,000 after acquiring an additional 11,468 shares in the last quarter. B&D White Capital Company LLC purchased a new position in shares of CVS Health in the 4th quarter valued at about $417,000. Watts Gwilliam & Co. LLC raised its position in shares of CVS Health by 9.8% during the 4th quarter. Watts Gwilliam & Co. LLC now owns 7,302 shares of the pharmacy operator’s stock worth $334,000 after acquiring an additional 650 shares in the last quarter. Finally, Seizert Capital Partners LLC lifted its stake in CVS Health by 22.8% during the fourth quarter. Seizert Capital Partners LLC now owns 569,527 shares of the pharmacy operator’s stock worth $25,566,000 after purchasing an additional 105,708 shares during the last quarter. Institutional investors and hedge funds own 80.66% of the company’s stock.

Insider Buying and Selling

In other CVS Health news, SVP James David Clark sold 7,513 shares of the firm’s stock in a transaction on Wednesday, March 5th. The stock was sold at an average price of $66.35, for a total transaction of $498,487.55. Following the completion of the transaction, the senior vice president now owns 8,394 shares of the company’s stock, valued at approximately $556,941.90. This trade represents a 47.23 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Michael F. Mahoney acquired 30,000 shares of CVS Health stock in a transaction dated Tuesday, February 18th. The stock was bought at an average price of $66.70 per share, for a total transaction of $2,001,000.00. Following the completion of the transaction, the director now directly owns 39,356 shares of the company’s stock, valued at approximately $2,625,045.20. This represents a 320.65 % increase in their ownership of the stock. The disclosure for this purchase can be found here. 1.22% of the stock is currently owned by insiders.

Analyst Ratings Changes

CVS has been the topic of a number of research analyst reports. Truist Financial raised their price objective on shares of CVS Health from $76.00 to $82.00 and gave the stock a “buy” rating in a report on Friday, April 11th. Wolfe Research boosted their price target on shares of CVS Health from 67.00 to 70.00 and gave the company an “overweight” rating in a research report on Tuesday, February 11th. Wells Fargo & Company raised their price objective on CVS Health from $68.00 to $73.00 and gave the stock an “overweight” rating in a report on Thursday, February 13th. Mizuho boosted their target price on CVS Health from $70.00 to $76.00 and gave the company an “outperform” rating in a report on Wednesday, April 9th. Finally, Leerink Partnrs raised CVS Health from a “hold” rating to a “strong-buy” rating in a research report on Wednesday, February 12th. Four equities research analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $71.83.

CVS Health Stock Performance

Shares of CVS stock opened at $65.30 on Friday. The company has a current ratio of 0.81, a quick ratio of 0.60 and a debt-to-equity ratio of 0.80. The stock has a 50 day simple moving average of $66.48 and a 200-day simple moving average of $58.87. The company has a market cap of $82.33 billion, a price-to-earnings ratio of 17.84, a price-to-earnings-growth ratio of 0.98 and a beta of 0.57. CVS Health Co. has a 12-month low of $43.56 and a 12-month high of $71.45.

CVS Health (NYSE:CVS) last released its quarterly earnings data on Wednesday, February 12th. The pharmacy operator reported $1.19 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.89 by $0.30. CVS Health had a return on equity of 9.11% and a net margin of 1.24%. On average, equities analysts forecast that CVS Health Co. will post 5.89 EPS for the current year.

CVS Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, May 1st. Investors of record on Tuesday, April 22nd will be paid a $0.665 dividend. This represents a $2.66 annualized dividend and a yield of 4.07%. The ex-dividend date is Tuesday, April 22nd. CVS Health’s payout ratio is currently 72.68%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.